Homework SourseInformation about from where subjects will be recruited base
Information about from where subjects will be recruited based on the blood sampling to test mir-22 in cancer pateints?
Solution
I have understood your question as \" what are the places conducting clincial trials on patients , where screening for miR-22 is done on cancer patients\"
I have retrieved the following clinical trials from clinicaltrials .gov registry, which shows the various hosptials/research centres conducting clinical trials on micro-RNA and cancer in US. miR-22 as such has only one study in egypt on COPD ( alung disease ) not on cancer. the list is exhaustive ,around 66 studies, hopefully it is useful for you.
Rank
NCT Number
Title
Recruitment
Conditions
Sponsor/Collaborators
Gender
URL
1
NCT02366494
Micro RNAs to Predict Response to Androgen Deprivation Therapy
Recruiting
Prostate Cancer
Medical College of Wisconsin
Male
https://ClinicalTrials.gov/show/NCT02366494
2
NCT02253251
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Recruiting
Cancer
MiraKind
Both
https://ClinicalTrials.gov/show/NCT02253251
3
NCT01231386
MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer
Recruiting
Breast Cancer
City of Hope Medical Center
Female
https://ClinicalTrials.gov/show/NCT01231386
4
NCT01541800
Circulating microRNAs as Disease Markers in Pediatric Cancers
Recruiting
Leukemia|Lymphoma|Central Nervous System
Ann & Robert H Lurie Children\'s Hospital of Chicago
Both
https://ClinicalTrials.gov/show/NCT01541800
5
NCT02464930
Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett\'s Esophagus and Associated Neoplasia
Recruiting
Barrett\'s Esophagus|Gastroesophageal Reflux|Esophageal Adenocarcinoma
Midwest Biomedical Research Foundation|Kansas City Veteran Affairs Medical Center|University of Kansas
Both
https://ClinicalTrials.gov/show/NCT02464930
6
NCT00806650
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
Active, not recruiting
Kidney Cancer
City of Hope Medical Center|National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT00806650
7
NCT02127073
Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer
Recruiting
Breast Cancer|Ductal Carcinoma in Situ
Sheldon Feldman|Columbia University
Female
https://ClinicalTrials.gov/show/NCT02127073
8
NCT02531607
Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds
Recruiting
Pancreatic Neoplasms
Florida Hospital
Both
https://ClinicalTrials.gov/show/NCT02531607
9
NCT01595126
Longitudinal Study of Biomarkers
Recruiting
Central Nervous System Tumor
Ann & Robert H Lurie Children\'s Hospital of Chicago
Both
https://ClinicalTrials.gov/show/NCT01595126
10
NCT00581750
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
Active, not recruiting
Breast Cancer|Lobular Carcinoma|Invasive Breast Cancer
Memorial Sloan Kettering Cancer Center
Female
https://ClinicalTrials.gov/show/NCT00581750
11
NCT01521039
Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
Recruiting
Acute Graft-versus-Host Disease|Allogeneic Stem Cell Transplant
Ohio State University Comprehensive Cancer Center
Both
https://ClinicalTrials.gov/show/NCT01521039
12
NCT01595139
MicroRNAs in Patients With Neurofibromatosis Type 1
Completed
Glioma|Neurofibromatosis Type 1
Ann & Robert H Lurie Children\'s Hospital of Chicago
Both
https://ClinicalTrials.gov/show/NCT01595139
13
NCT01849952
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
Recruiting
Astrocytoma|Oligodendroglioma|Oligoastrocytoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma|Glioblastoma|Brain Tumors|Brain Cancer
Dartmouth-Hitchcock Medical Center
Both
https://ClinicalTrials.gov/show/NCT01849952
14
NCT02412579
Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation
Recruiting
Hepatocellular Carcinoma
Baylor Research Institute
Both
https://ClinicalTrials.gov/show/NCT02412579
15
NCT01556178
Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research
Completed
Hydrocephalus
Ann & Robert H Lurie Children\'s Hospital of Chicago
Both
https://ClinicalTrials.gov/show/NCT01556178
16
NCT02402036
A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer
Recruiting
Colon Cancer
Georgetown University|Bayer
Both
https://ClinicalTrials.gov/show/NCT02402036
17
NCT00909350
Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue
Completed
Barrett\'s Esophagus|Esophageal Adenocarcinoma
Mayo Clinic
Both
https://ClinicalTrials.gov/show/NCT00909350
18
NCT01433809
Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm
Completed
Cancer of the Thyroid|Neoplasms, Thyroid|Thyroid Adenoma|Thyroid Cancer|Thyroid Carcinoma
Norman Eberhardt|Mayo Clinic
Both
https://ClinicalTrials.gov/show/NCT01433809
19
NCT00897234
Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers
Completed
Lung Cancer
University of Minnesota - Clinical and Translational Science Institute
Both
https://ClinicalTrials.gov/show/NCT00897234
20
NCT01336881
Biomarkers in Tissue Samples From Young Patients With Liver Cancer
Completed
Childhood Hepatoblastoma|Stage I Childhood Liver Cancer|Stage II Childhood Liver Cancer|Stage III Childhood Liver Cancer|Stage IV Childhood Liver Cancer
Children\'s Oncology Group|National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT01336881
21
NCT01240590
A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Active, not recruiting
Solid Tumor|Anaplastic Thyroid Cancer
National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Both
https://ClinicalTrials.gov/show/NCT01240590
22
NCT01970696
International Ovarian & Testicular Stromal Tumor Registry
Recruiting
Ovarian Stromal Tumor|Testicular Stromal Tumors|Ovarian Small Cell Carcinoma
Children\'s Hospitals and Clinics of Minnesota|Children\'s Research Institute|Dana-Farber Cancer Institute|Washington University School of Medicine|University of Texas Southwestern Medical Center|M.D. Anderson Cancer Center|Children\'s Hospital Medical Center, Cincinnati|Children\'s Hospital Colorado|Rutgers University|Massachusetts General Hospital|National Cancer Institute (NCI)|Klinikum Dortmund Wirbelsäulenchirurgie
Both
https://ClinicalTrials.gov/show/NCT01970696
23
NCT02392377
Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy
Terminated
Stage IB Esophageal Adenocarcinoma|Stage IIA Esophageal Adenocarcinoma|Stage IIB Esophageal Adenocarcinoma|Stage IIIA Esophageal Adenocarcinoma|Stage IIIB Esophageal Adenocarcinoma|Stage IIIC Esophageal Adenocarcinoma
Case Comprehensive Cancer Center|National Cancer Institute (NCI)
Male
https://ClinicalTrials.gov/show/NCT02392377
24
NCT02103140
An Exercise RCT Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer
Active, not recruiting
Metabolic Syndrome|Obesity
Georgetown University
Female
https://ClinicalTrials.gov/show/NCT02103140
25
NCT01829971
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
Terminated
Primary Liver Cancer|SCLC|Lymphoma|Melanoma|Multiple Myeloma|Renal Cell Carcinoma|NSCLC
Mirna Therapeutics, Inc.|Cancer Prevention Research Institute of Texas
Both
https://ClinicalTrials.gov/show/NCT01829971
26
NCT01141530
Deep Sequencing of the Breast Cancer Transcriptome
Withdrawn
Breast Cancer
University of Arkansas
Female
https://ClinicalTrials.gov/show/NCT01141530
27
NCT00898092
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia
Active, not recruiting
Leukemia
Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT00898092
28
NCT01247597
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Recruiting
Pleuropulmonary Blastoma|Cystic Nephroma|Ovarian Sertoli-Leydig Cell Tumors|Ocular Medulloepithelioma|Nasal Chondromesenchymal Hamartoma
National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Both
https://ClinicalTrials.gov/show/NCT01247597
29
NCT02917148
MicroRNAs as Diagnostic and Predictive Biomarkers for Acute Graft Versus Host Disease
Recruiting
Acute GVH Disease
Northwell Health
Both
https://ClinicalTrials.gov/show/NCT02917148
30
NCT01984580
Effect of Zinc on Barrett\'s Metaplasia
Unknown status
Barrett\'s Metaplasia
Main Line Health|Sharpe-Strumia Research Foundation
Both
https://ClinicalTrials.gov/show/NCT01984580
31
NCT00958659
Study of Specimens From Young Patients With Neuroblastoma
Completed
Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Regional Neuroblastoma|Stage 4S Neuroblastoma
Children\'s Oncology Group|National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT00958659
32
NCT00926640
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
Suspended
Carcinoma Neuroendocrine|Small Cell Lung Carcinoma|Malignant Epithelial Neoplasms
National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Both
https://ClinicalTrials.gov/show/NCT00926640
33
NCT01132586
Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
Completed
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1|Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL|Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA|Alkylating Agent-Related Acute Myeloid Leukemia|de Novo Myelodysplastic Syndrome|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndrome|Untreated Adult Acute Myeloid Leukemia
National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT01132586
34
NCT00565903
Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome
Recruiting
Pleuropulmonary Blastoma|Cystic Nephroma|Sertoli-Leydig Cell Tumor of Ovary|Medulloepithelioma|Embryonal Rhabdomyosarcoma of Cervix|Goiter|Sarcoma|Pineoblastoma|Pituitary Tumors|Wilms Tumor
D. Ashley Hill, M.D.|Children\'s Research Institute
Both
https://ClinicalTrials.gov/show/NCT00565903
35
NCT02328677
ColoCare Study - Colorectal Cancer Cohort
Recruiting
Colorectal Cancer
Fred Hutchinson Cancer Research Center|German Cancer Research Center|H. Lee Moffitt Cancer Center and Research Institute|Huntsman Cancer Institute
Both
https://ClinicalTrials.gov/show/NCT02328677
36
NCT01503229
Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Active, not recruiting
Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Adenocarcinoma
University of Washington|National Cancer Institute (NCI)
Male
https://ClinicalTrials.gov/show/NCT01503229
37
NCT00764517
Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin\'s Lymphoma
Active, not recruiting
Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Indolent Adult Non-Hodgkin Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute|National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT00764517
38
NCT00624936
Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Unknown status
Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms
Ohio State University Comprehensive Cancer Center|National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT00624936
39
NCT01050296
Molecular Analysis Of Solid Tumors
Recruiting
Pediatric Solid Tumors
St. Jude Children\'s Research Hospital|Alex\'s Lemonade Stand Foundation
Both
https://ClinicalTrials.gov/show/NCT01050296
40
NCT02724202
Curcumin in Combination With 5FU for Colon Cancer
Recruiting
Metastatic Colon Cancer
Baylor Research Institute
Both
https://ClinicalTrials.gov/show/NCT02724202
41
NCT00896766
Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia
Completed
Leukemia
Children\'s Oncology Group|National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT00896766
42
NCT02243592
Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
Recruiting
Malignant Neoplasm
National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT02243592
43
NCT01555268
Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
Active, not recruiting
Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Recurrent Adult Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia
Roswell Park Cancer Institute|National Cancer Institute (NCI)|Amgen
Both
https://ClinicalTrials.gov/show/NCT01555268
44
NCT01144169
Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
Terminated
Renal Cell Carcinoma
University of Pittsburgh|National Institutes of Health (NIH)
Both
https://ClinicalTrials.gov/show/NCT01144169
45
NCT02983279
Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer
Recruiting
Breast Carcinoma|Endometrial Carcinoma|Prostate Carcinosarcoma
Sidney Kimmel Cancer Center at Thomas Jefferson University|Thomas Jefferson University
Both
https://ClinicalTrials.gov/show/NCT02983279
46
NCT00900224
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Active, not recruiting
Leukemia
Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT00900224
47
NCT01658319
Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies
Completed
Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Peripheral T-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage III Chronic Lymphocytic Leukemia|Testicular Lymphoma|Waldenström Macroglobulinemia
Case Comprehensive Cancer Center|National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT01658319
48
NCT00997243
Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes
Terminated
Leukemia|Myelodysplastic Syndromes
Alison Walker|Seattle Genetics, Inc.|Ohio State University Comprehensive Cancer Center
Both
https://ClinicalTrials.gov/show/NCT00997243
49
NCT02169271
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules
Recruiting
Current Smoker|Former Smoker|Pulmonary Nodules|Tobacco Use Disorder
National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT02169271
50
NCT01129180
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Completed
Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Hepatosplenic T-cell Lymphoma|Peripheral T-cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Prolymphocytic Leukemia|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Small Intestine Lymphoma|T-cell Large Granular Lymphocyte Leukemia
Pierluigi Porcu|Millennium Pharmaceuticals, Inc.|Celgene Corporation|Ohio State University Comprehensive Cancer Center
Both
https://ClinicalTrials.gov/show/NCT01129180
51
NCT01216787
RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery
Withdrawn
Stage IIIB Melanoma|Stage IIIC Melanoma|Stage IV Melanoma
National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT01216787
52
NCT02052908
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
Recruiting
Lynch Syndrome
National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT02052908
53
NCT01999972
A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors
Recruiting
Advanced Solid Tumors
Pfizer
Both
https://ClinicalTrials.gov/show/NCT01999972
54
NCT01780662
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma
Active, not recruiting
Recurrent Adult Hodgkin Lymphoma|Recurrent Childhood Hodgkin Lymphoma|Refractory Childhood Hodgkin Lymphoma
National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT01780662
55
NCT02657005
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
Recruiting
Sarcoma, Ewing
Tokalas, Inc.
Both
https://ClinicalTrials.gov/show/NCT02657005
56
NCT01120236
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Active, not recruiting
Prostate Adenocarcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer
National Cancer Institute (NCI)
Male
https://ClinicalTrials.gov/show/NCT01120236
57
NCT02437318
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.
Recruiting
Breast Cancer
Novartis Pharmaceuticals|Novartis
Both
https://ClinicalTrials.gov/show/NCT02437318
58
NCT01210495
Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
Active, not recruiting
Hepatocellular Carcinoma
Pfizer
Both
https://ClinicalTrials.gov/show/NCT01210495
59
NCT01289717
Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients
Completed
Kidney Transplant|Kidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation
Both
https://ClinicalTrials.gov/show/NCT01289717
60
NCT01698177
Optimizing Influenza Vaccination in Surgical Oncology Patients
Unknown status
Influenza
Stony Brook University
Both
https://ClinicalTrials.gov/show/NCT01698177
61
NCT01672164
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
Completed
Liver Transplant Recipients|Liver Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation
Both
https://ClinicalTrials.gov/show/NCT01672164
62
NCT02352389
A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents
Recruiting
Influenza, Human
St. Jude Children\'s Research Hospital
Both
https://ClinicalTrials.gov/show/NCT02352389
63
NCT02736357
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
Recruiting
Non-Hodgkin Lymphoma
Mayo Clinic|Emory University|University of Iowa|M.D. Anderson Cancer Center|Washington University School of Medicine|University of Rochester|Weill Medical College of Cornell University|University of Miami
Both
https://ClinicalTrials.gov/show/NCT02736357
64
NCT02077998
Oxaliplatin in Treating Patients With Metastatic Breast Cancer
Completed
Stage IV Breast Cancer
University of California, Davis|National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT02077998
65
NCT02935478
Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation
Not yet recruiting
Obesity|Weight Loss|Body Weight|Hepatocellular Carcinoma|HCC|Hepatitis C|Cirrhosis
St. Louis University
Both
https://ClinicalTrials.gov/show/NCT02935478
66
NCT02169284
Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery
Recruiting
Bladder Carcinoma|Recurrent Bladder Carcinoma
National Cancer Institute (NCI)
Both
https://ClinicalTrials.gov/show/NCT02169284
| Rank | NCT Number | Title | Recruitment | Conditions | Sponsor/Collaborators | Gender | URL |
| 1 | NCT02366494 | Micro RNAs to Predict Response to Androgen Deprivation Therapy | Recruiting | Prostate Cancer | Medical College of Wisconsin | Male | https://ClinicalTrials.gov/show/NCT02366494 |
| 2 | NCT02253251 | Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment | Recruiting | Cancer | MiraKind | Both | https://ClinicalTrials.gov/show/NCT02253251 |
| 3 | NCT01231386 | MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer | Recruiting | Breast Cancer | City of Hope Medical Center | Female | https://ClinicalTrials.gov/show/NCT01231386 |
| 4 | NCT01541800 | Circulating microRNAs as Disease Markers in Pediatric Cancers | Recruiting | Leukemia|Lymphoma|Central Nervous System | Ann & Robert H Lurie Children\'s Hospital of Chicago | Both | https://ClinicalTrials.gov/show/NCT01541800 |
| 5 | NCT02464930 | Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett\'s Esophagus and Associated Neoplasia | Recruiting | Barrett\'s Esophagus|Gastroesophageal Reflux|Esophageal Adenocarcinoma | Midwest Biomedical Research Foundation|Kansas City Veteran Affairs Medical Center|University of Kansas | Both | https://ClinicalTrials.gov/show/NCT02464930 |
| 6 | NCT00806650 | Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer | Active, not recruiting | Kidney Cancer | City of Hope Medical Center|National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT00806650 |
| 7 | NCT02127073 | Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer | Recruiting | Breast Cancer|Ductal Carcinoma in Situ | Sheldon Feldman|Columbia University | Female | https://ClinicalTrials.gov/show/NCT02127073 |
| 8 | NCT02531607 | Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds | Recruiting | Pancreatic Neoplasms | Florida Hospital | Both | https://ClinicalTrials.gov/show/NCT02531607 |
| 9 | NCT01595126 | Longitudinal Study of Biomarkers | Recruiting | Central Nervous System Tumor | Ann & Robert H Lurie Children\'s Hospital of Chicago | Both | https://ClinicalTrials.gov/show/NCT01595126 |
| 10 | NCT00581750 | Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ | Active, not recruiting | Breast Cancer|Lobular Carcinoma|Invasive Breast Cancer | Memorial Sloan Kettering Cancer Center | Female | https://ClinicalTrials.gov/show/NCT00581750 |
| 11 | NCT01521039 | Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease | Recruiting | Acute Graft-versus-Host Disease|Allogeneic Stem Cell Transplant | Ohio State University Comprehensive Cancer Center | Both | https://ClinicalTrials.gov/show/NCT01521039 |
| 12 | NCT01595139 | MicroRNAs in Patients With Neurofibromatosis Type 1 | Completed | Glioma|Neurofibromatosis Type 1 | Ann & Robert H Lurie Children\'s Hospital of Chicago | Both | https://ClinicalTrials.gov/show/NCT01595139 |
| 13 | NCT01849952 | Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas | Recruiting | Astrocytoma|Oligodendroglioma|Oligoastrocytoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma|Glioblastoma|Brain Tumors|Brain Cancer | Dartmouth-Hitchcock Medical Center | Both | https://ClinicalTrials.gov/show/NCT01849952 |
| 14 | NCT02412579 | Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation | Recruiting | Hepatocellular Carcinoma | Baylor Research Institute | Both | https://ClinicalTrials.gov/show/NCT02412579 |
| 15 | NCT01556178 | Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research | Completed | Hydrocephalus | Ann & Robert H Lurie Children\'s Hospital of Chicago | Both | https://ClinicalTrials.gov/show/NCT01556178 |
| 16 | NCT02402036 | A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer | Recruiting | Colon Cancer | Georgetown University|Bayer | Both | https://ClinicalTrials.gov/show/NCT02402036 |
| 17 | NCT00909350 | Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue | Completed | Barrett\'s Esophagus|Esophageal Adenocarcinoma | Mayo Clinic | Both | https://ClinicalTrials.gov/show/NCT00909350 |
| 18 | NCT01433809 | Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm | Completed | Cancer of the Thyroid|Neoplasms, Thyroid|Thyroid Adenoma|Thyroid Cancer|Thyroid Carcinoma | Norman Eberhardt|Mayo Clinic | Both | https://ClinicalTrials.gov/show/NCT01433809 |
| 19 | NCT00897234 | Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers | Completed | Lung Cancer | University of Minnesota - Clinical and Translational Science Institute | Both | https://ClinicalTrials.gov/show/NCT00897234 |
| 20 | NCT01336881 | Biomarkers in Tissue Samples From Young Patients With Liver Cancer | Completed | Childhood Hepatoblastoma|Stage I Childhood Liver Cancer|Stage II Childhood Liver Cancer|Stage III Childhood Liver Cancer|Stage IV Childhood Liver Cancer | Children\'s Oncology Group|National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT01336881 |
| 21 | NCT01240590 | A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) | Active, not recruiting | Solid Tumor|Anaplastic Thyroid Cancer | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) | Both | https://ClinicalTrials.gov/show/NCT01240590 |
| 22 | NCT01970696 | International Ovarian & Testicular Stromal Tumor Registry | Recruiting | Ovarian Stromal Tumor|Testicular Stromal Tumors|Ovarian Small Cell Carcinoma | Children\'s Hospitals and Clinics of Minnesota|Children\'s Research Institute|Dana-Farber Cancer Institute|Washington University School of Medicine|University of Texas Southwestern Medical Center|M.D. Anderson Cancer Center|Children\'s Hospital Medical Center, Cincinnati|Children\'s Hospital Colorado|Rutgers University|Massachusetts General Hospital|National Cancer Institute (NCI)|Klinikum Dortmund Wirbelsäulenchirurgie | Both | https://ClinicalTrials.gov/show/NCT01970696 |
| 23 | NCT02392377 | Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy | Terminated | Stage IB Esophageal Adenocarcinoma|Stage IIA Esophageal Adenocarcinoma|Stage IIB Esophageal Adenocarcinoma|Stage IIIA Esophageal Adenocarcinoma|Stage IIIB Esophageal Adenocarcinoma|Stage IIIC Esophageal Adenocarcinoma | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Male | https://ClinicalTrials.gov/show/NCT02392377 |
| 24 | NCT02103140 | An Exercise RCT Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer | Active, not recruiting | Metabolic Syndrome|Obesity | Georgetown University | Female | https://ClinicalTrials.gov/show/NCT02103140 |
| 25 | NCT01829971 | A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | Terminated | Primary Liver Cancer|SCLC|Lymphoma|Melanoma|Multiple Myeloma|Renal Cell Carcinoma|NSCLC | Mirna Therapeutics, Inc.|Cancer Prevention Research Institute of Texas | Both | https://ClinicalTrials.gov/show/NCT01829971 |
| 26 | NCT01141530 | Deep Sequencing of the Breast Cancer Transcriptome | Withdrawn | Breast Cancer | University of Arkansas | Female | https://ClinicalTrials.gov/show/NCT01141530 |
| 27 | NCT00898092 | Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia | Active, not recruiting | Leukemia | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT00898092 |
| 28 | NCT01247597 | DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study | Recruiting | Pleuropulmonary Blastoma|Cystic Nephroma|Ovarian Sertoli-Leydig Cell Tumors|Ocular Medulloepithelioma|Nasal Chondromesenchymal Hamartoma | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) | Both | https://ClinicalTrials.gov/show/NCT01247597 |
| 29 | NCT02917148 | MicroRNAs as Diagnostic and Predictive Biomarkers for Acute Graft Versus Host Disease | Recruiting | Acute GVH Disease | Northwell Health | Both | https://ClinicalTrials.gov/show/NCT02917148 |
| 30 | NCT01984580 | Effect of Zinc on Barrett\'s Metaplasia | Unknown status | Barrett\'s Metaplasia | Main Line Health|Sharpe-Strumia Research Foundation | Both | https://ClinicalTrials.gov/show/NCT01984580 |
| 31 | NCT00958659 | Study of Specimens From Young Patients With Neuroblastoma | Completed | Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Regional Neuroblastoma|Stage 4S Neuroblastoma | Children\'s Oncology Group|National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT00958659 |
| 32 | NCT00926640 | A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers | Suspended | Carcinoma Neuroendocrine|Small Cell Lung Carcinoma|Malignant Epithelial Neoplasms | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) | Both | https://ClinicalTrials.gov/show/NCT00926640 |
| 33 | NCT01132586 | Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia | Completed | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1|Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL|Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA|Alkylating Agent-Related Acute Myeloid Leukemia|de Novo Myelodysplastic Syndrome|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndrome|Untreated Adult Acute Myeloid Leukemia | National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT01132586 |
| 34 | NCT00565903 | Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome | Recruiting | Pleuropulmonary Blastoma|Cystic Nephroma|Sertoli-Leydig Cell Tumor of Ovary|Medulloepithelioma|Embryonal Rhabdomyosarcoma of Cervix|Goiter|Sarcoma|Pineoblastoma|Pituitary Tumors|Wilms Tumor | D. Ashley Hill, M.D.|Children\'s Research Institute | Both | https://ClinicalTrials.gov/show/NCT00565903 |
| 35 | NCT02328677 | ColoCare Study - Colorectal Cancer Cohort | Recruiting | Colorectal Cancer | Fred Hutchinson Cancer Research Center|German Cancer Research Center|H. Lee Moffitt Cancer Center and Research Institute|Huntsman Cancer Institute | Both | https://ClinicalTrials.gov/show/NCT02328677 |
| 36 | NCT01503229 | Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | Active, not recruiting | Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Adenocarcinoma | University of Washington|National Cancer Institute (NCI) | Male | https://ClinicalTrials.gov/show/NCT01503229 |
| 37 | NCT00764517 | Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin\'s Lymphoma | Active, not recruiting | Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Indolent Adult Non-Hodgkin Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma | OHSU Knight Cancer Institute|National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT00764517 |
| 38 | NCT00624936 | Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes | Unknown status | Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms | Ohio State University Comprehensive Cancer Center|National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT00624936 |
| 39 | NCT01050296 | Molecular Analysis Of Solid Tumors | Recruiting | Pediatric Solid Tumors | St. Jude Children\'s Research Hospital|Alex\'s Lemonade Stand Foundation | Both | https://ClinicalTrials.gov/show/NCT01050296 |
| 40 | NCT02724202 | Curcumin in Combination With 5FU for Colon Cancer | Recruiting | Metastatic Colon Cancer | Baylor Research Institute | Both | https://ClinicalTrials.gov/show/NCT02724202 |
| 41 | NCT00896766 | Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia | Completed | Leukemia | Children\'s Oncology Group|National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT00896766 |
| 42 | NCT02243592 | Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment | Recruiting | Malignant Neoplasm | National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT02243592 |
| 43 | NCT01555268 | Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia | Active, not recruiting | Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Recurrent Adult Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia | Roswell Park Cancer Institute|National Cancer Institute (NCI)|Amgen | Both | https://ClinicalTrials.gov/show/NCT01555268 |
| 44 | NCT01144169 | Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma | Terminated | Renal Cell Carcinoma | University of Pittsburgh|National Institutes of Health (NIH) | Both | https://ClinicalTrials.gov/show/NCT01144169 |
| 45 | NCT02983279 | Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer | Recruiting | Breast Carcinoma|Endometrial Carcinoma|Prostate Carcinosarcoma | Sidney Kimmel Cancer Center at Thomas Jefferson University|Thomas Jefferson University | Both | https://ClinicalTrials.gov/show/NCT02983279 |
| 46 | NCT00900224 | Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia | Active, not recruiting | Leukemia | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT00900224 |
| 47 | NCT01658319 | Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies | Completed | Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Peripheral T-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage III Chronic Lymphocytic Leukemia|Testicular Lymphoma|Waldenström Macroglobulinemia | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT01658319 |
| 48 | NCT00997243 | Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes | Terminated | Leukemia|Myelodysplastic Syndromes | Alison Walker|Seattle Genetics, Inc.|Ohio State University Comprehensive Cancer Center | Both | https://ClinicalTrials.gov/show/NCT00997243 |
| 49 | NCT02169271 | Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules | Recruiting | Current Smoker|Former Smoker|Pulmonary Nodules|Tobacco Use Disorder | National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT02169271 |
| 50 | NCT01129180 | Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma | Completed | Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Hepatosplenic T-cell Lymphoma|Peripheral T-cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Prolymphocytic Leukemia|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Small Intestine Lymphoma|T-cell Large Granular Lymphocyte Leukemia | Pierluigi Porcu|Millennium Pharmaceuticals, Inc.|Celgene Corporation|Ohio State University Comprehensive Cancer Center | Both | https://ClinicalTrials.gov/show/NCT01129180 |
| 51 | NCT01216787 | RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery | Withdrawn | Stage IIIB Melanoma|Stage IIIC Melanoma|Stage IV Melanoma | National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT01216787 |
| 52 | NCT02052908 | Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome | Recruiting | Lynch Syndrome | National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT02052908 |
| 53 | NCT01999972 | A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors | Recruiting | Advanced Solid Tumors | Pfizer | Both | https://ClinicalTrials.gov/show/NCT01999972 |
| 54 | NCT01780662 | Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma | Active, not recruiting | Recurrent Adult Hodgkin Lymphoma|Recurrent Childhood Hodgkin Lymphoma|Refractory Childhood Hodgkin Lymphoma | National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT01780662 |
| 55 | NCT02657005 | TK216 in Patients With Relapsed or Refractory Ewing Sarcoma | Recruiting | Sarcoma, Ewing | Tokalas, Inc. | Both | https://ClinicalTrials.gov/show/NCT02657005 |
| 56 | NCT01120236 | Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer | Active, not recruiting | Prostate Adenocarcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer | National Cancer Institute (NCI) | Male | https://ClinicalTrials.gov/show/NCT01120236 |
| 57 | NCT02437318 | Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment. | Recruiting | Breast Cancer | Novartis Pharmaceuticals|Novartis | Both | https://ClinicalTrials.gov/show/NCT02437318 |
| 58 | NCT01210495 | Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma | Active, not recruiting | Hepatocellular Carcinoma | Pfizer | Both | https://ClinicalTrials.gov/show/NCT01210495 |
| 59 | NCT01289717 | Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients | Completed | Kidney Transplant|Kidney Transplantation | National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation | Both | https://ClinicalTrials.gov/show/NCT01289717 |
| 60 | NCT01698177 | Optimizing Influenza Vaccination in Surgical Oncology Patients | Unknown status | Influenza | Stony Brook University | Both | https://ClinicalTrials.gov/show/NCT01698177 |
| 61 | NCT01672164 | Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients | Completed | Liver Transplant Recipients|Liver Transplantation | National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation | Both | https://ClinicalTrials.gov/show/NCT01672164 |
| 62 | NCT02352389 | A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents | Recruiting | Influenza, Human | St. Jude Children\'s Research Hospital | Both | https://ClinicalTrials.gov/show/NCT02352389 |
| 63 | NCT02736357 | The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study | Recruiting | Non-Hodgkin Lymphoma | Mayo Clinic|Emory University|University of Iowa|M.D. Anderson Cancer Center|Washington University School of Medicine|University of Rochester|Weill Medical College of Cornell University|University of Miami | Both | https://ClinicalTrials.gov/show/NCT02736357 |
| 64 | NCT02077998 | Oxaliplatin in Treating Patients With Metastatic Breast Cancer | Completed | Stage IV Breast Cancer | University of California, Davis|National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT02077998 |
| 65 | NCT02935478 | Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation | Not yet recruiting | Obesity|Weight Loss|Body Weight|Hepatocellular Carcinoma|HCC|Hepatitis C|Cirrhosis | St. Louis University | Both | https://ClinicalTrials.gov/show/NCT02935478 |
| 66 | NCT02169284 | Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery | Recruiting | Bladder Carcinoma|Recurrent Bladder Carcinoma | National Cancer Institute (NCI) | Both | https://ClinicalTrials.gov/show/NCT02169284 |
